Home LiteratureArticle Details
PMID: 11564657 Published · ppublish English Comparative Study Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

RNA-editing of the 5-HT(2C) receptor alters agonist-receptor-effector coupling specificity.

British journal of pharmacology ·Vol. 134 ·No. 2 ·2001-09-00 ·Pages 386-92

Berg KA, Cropper JD, Niswender CM, Sanders-Bush E, Emeson RB, Clarke WP

Abstract

1. The serotonin(2C) (5-HT(2C)) receptor couples to both phospholipase C (PLC)-inositol phosphate (IP) and phospholipase A(2) (PLA(2))-arachidonic acid (AA) signalling cascades. Agonists can differentially activate these effectors (i.e. agonist-directed trafficking of receptor stimulus) perhaps due to agonist-specific receptor conformations which differentially couple to/activate transducer molecules (e.g. G proteins). Since editing of RNA transcripts of the human 5-HT(2C) receptor leads to substitution of amino acids at positions 156, 158 and 160 of the putative second intracellular loop, a region important for G protein coupling, we examined the capacity of agonists to activate both the PLC-IP and PLA(2)-AA pathways in CHO cells stably expressing two major, fully RNA-edited isoforms (5-HT(2C-VSV), 5-HT(2C-VGV)) of the h5-HT(2C) receptor. 2. 5-HT increased AA release and IP accumulation in both 5-HT(2C-VSV) and 5-HT(2C-VGV) expressing cells. As expected, the potency of 5-HT for both RNA-edited isoforms for both responses was 10 fold lower relative to that of the non-edited receptor (5-HT(2C-INI)) when receptors were expressed at similar levels. 3. Consistent with our previous report, the efficacy order of two 5-HT receptor agonists (TFMPP and bufotenin) was reversed for AA release and IP accumulation at the non-edited receptor thus demonstrating agonist trafficking of receptor stimulus. However, with the RNA-edited receptor isoforms there was no difference in the relative efficacies of TFMPP or bufotenin for AA release and IP accumulation suggesting that the capacity for 5-HT(2C) agonists to traffic receptor stimulus is lost as a result of RNA editing. 4. These results suggest an important role for the second intracellular loop in transmitting agonist-specific information to signalling molecules.

MeSH Terms
Amphetamines/pharmacology Animals Arachidonic Acid/metabolism Binding, Competitive/drug effects Bufotenin/pharmacology CHO Cells Cricetinae Dose-Response Relationship, Drug Ergolines/metabolism Inositol Phosphates/metabolism Lysergic Acid Diethylamide/pharmacology Piperazines/pharmacology Protein Isoforms/genetics,metabolism Quipazine/pharmacology RNA Editing Radioligand Assay Receptor, Serotonin, 5-HT2C Receptors, Serotonin/genetics,metabolism Serotonin/pharmacology Serotonin Receptor Agonists/metabolism,pharmacology Tritium
Chemicals
Amphetamines Ergolines Inositol Phosphates Piperazines Protein Isoforms Receptor, Serotonin, 5-HT2C Receptors, Serotonin Serotonin Receptor Agonists Bufotenin Tritium 1-(3-trifluoromethylphenyl)piperazine Arachidonic Acid Serotonin Quipazine Lysergic Acid Diethylamide 4-iodo-2,5-dimethoxyphenylisopropylamine mesulergine
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Berg K A
Department of Pharmacology, Mail Code 7764, University of Texas Health Science Center, San Antonio, Texas, TX 78229-3900, USA. berg@uthscsa.edu
Cropper J D
Niswender C M
Sanders-Bush E
Emeson R B
Clarke W P
References (26)
26 references, click to expand
  1. Agonist-directed signaling of serotonin 5-HT2C receptors: differences between serotonin and lysergic acid diethylamide (LSD).
    Neuropsychopharmacology. 1999 Aug;21(2 Suppl):77S-81S PMID: 10432492
  2. Differential involvement of Galpha12 and Galpha13 in receptor-mediated stress fiber formation.
    J Biol Chem. 1999 Jun 18;274(25):17901-7 PMID: 10364236
  3. Serotonin 5-HT2C receptor RNA editing alters receptor basal activity: implications for serotonergic signal transduction.
    J Neurochem. 1999 Oct;73(4):1711-7 PMID: 10501219
  4. Dissecting G protein-coupled receptor signaling pathways with membrane-permeable blocking peptides. Endogenous 5-HT(2C) receptors in choroid plexus epithelial cells.
    J Biol Chem. 2000 Mar 10;275(10):7021-9 PMID: 10702266
  5. Agonist-directed trafficking of porcine alpha(2A)-adrenergic receptor signaling in Chinese hamster ovary cells: l-isoproterenol selectively activates G(s).
    J Pharmacol Exp Ther. 2000 Aug;294(2):539-47 PMID: 10900230
  6. Influence of receptor number on functional responses elicited by agonists acting at the human adenosine A(1) receptor: evidence for signaling pathway-dependent changes in agonist potency and relative intrinsic activity.
    Mol Pharmacol. 2000 Nov;58(5):1075-84 PMID: 11040056
  7. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.
    Biochem Pharmacol. 1973 Dec 1;22(23):3099-108 PMID: 4202581
  8. A unique serotonin receptor in choroid plexus is linked to phosphatidylinositol turnover.
    Proc Natl Acad Sci U S A. 1986 Jun;83(11):4086-8 PMID: 2940597
  9. Differential signal transduction by five splice variants of the PACAP receptor.
    Nature. 1993 Sep 9;365(6442):170-5 PMID: 8396727
  10. Agonist-specific coupling of a cloned Drosophila octopamine/tyramine receptor to multiple second messenger systems.
    EMBO J. 1994 Mar 15;13(6):1325-30 PMID: 8137817
  11. Signal transduction differences between 5-hydroxytryptamine type 2A and type 2C receptor systems.
    Mol Pharmacol. 1994 Sep;46(3):477-84 PMID: 7935328
  12. Serotonin 5-HT2C receptor stimulates cyclic GMP formation in choroid plexus.
    J Neurochem. 1995 Jan;64(1):199-205 PMID: 7798914
  13. Agonist-receptor efficacy. II. Agonist trafficking of receptor signals.
    Trends Pharmacol Sci. 1995 Jul;16(7):232-8 PMID: 7667897
  14. RNA editing.
    Annu Rev Neurosci. 1996;19:27-52 PMID: 8833435
  15. 5-hydroxytryptamine2C receptor activation inhibits 5-hydroxytryptamine1B-like receptor function via arachidonic acid metabolism.
    Mol Pharmacol. 1996 Oct;50(4):1017-23 PMID: 8863849
  16. Characterization of a 5-HT1B receptor on CHO cells: functional responses in the absence of radioligand binding.
    Br J Pharmacol. 1996 Mar;117(6):1119-26 PMID: 8882605
  17. Functional and structural complexity of signal transduction via G-protein-coupled receptors.
    Annu Rev Neurosci. 1997;20:399-427 PMID: 9056720
  18. Regulation of serotonin-2C receptor G-protein coupling by RNA editing.
    Nature. 1997 May 15;387(6630):303-8 PMID: 9153397
  19. A guide to RNA editing.
    RNA. 1997 Oct;3(10):1105-23 PMID: 9326486
  20. Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: evidence for agonist-directed trafficking of receptor stimulus.
    Mol Pharmacol. 1998 Jul;54(1):94-104 PMID: 9658194
  21. The elusive nature of intrinsic efficacy.
    Trends Pharmacol Sci. 1998 Jul;19(7):270-6 PMID: 9703760
  22. 5-Hydroxytryptamine2-family receptors (5-hydroxytryptamine2A, 5-hydroxytryptamine2B, 5-hydroxytryptamine2C): where structure meets function.
    Pharmacol Ther. 1998 Sep;79(3):231-57 PMID: 9776378
  23. RNA editing of the human serotonin 5-hydroxytryptamine 2C receptor silences constitutive activity.
    J Biol Chem. 1999 Apr 2;274(14):9472-8 PMID: 10092629
  24. Novel actions of inverse agonists on 5-HT2C receptor systems.
    Mol Pharmacol. 1999 May;55(5):863-72 PMID: 10220565
  25. Heptahelical receptor signaling: beyond the G protein paradigm.
    J Cell Biol. 1999 May 31;145(5):927-32 PMID: 10352011
  26. Messenger RNA editing of the human serotonin 5-HT2C receptor.
    Neuropsychopharmacology. 1999 Aug;21(2 Suppl):82S-90S PMID: 10432493
Article Info
Journal
British journal of pharmacology
Abbr.
Br J Pharmacol
ISSN
0007-1188
Published
2001-09-00
Pages
386-92
Language
English
Region
England
NLM ID
7502536
PMCID
PMC1572953
Subset
IM
Grants
NINDS NIH HHS · NS36891 · United States
NIGMS NIH HHS · GM 58652 · United States
NIDA NIH HHS · DA 09094 · United States
NIMH NIH HHS · MH34005 · United States
NIGMS NIH HHS · R01 GM058652 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com